A team of researchers has developed a novel method for improving drug testing for esophageal cancer using 3D cell culture technology. They created a tumor spheroid model on a chip with inverse opal hydrogel scaffolds to better mimic tumor environments. This platform allows for more accurate assessment of chemotherapeutic agents by simulating physiological conditions cancer cells encounter in the body. The microfluidic chip integrates the scaffold and enables high-throughput drug screening. This approach has the potential to revolutionize chemotherapy drug development, and the researchers aim to further refine the chip for use in screening drugs for a variety of diseases.
Source link
How tiny tumor models could transform drug testing
